• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经病理性疼痛的筛查工具:它们对脊髓损伤患者有用吗?

Screening tools for neuropathic pain: can they be of use in individuals with spinal cord injury?

机构信息

Department of Physiotherapy, Karolinska University Hospital, Stockholm, Sweden Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden Department of Neuroscience, Uppsala University, Section of Physiotherapy, Uppsala, Sweden.

出版信息

Pain. 2011 Apr;152(4):772-779. doi: 10.1016/j.pain.2010.11.019. Epub 2011 Jan 26.

DOI:10.1016/j.pain.2010.11.019
PMID:21272997
Abstract

Pain of both neuropathic and nociceptive aetiology is common after spinal cord injury (SCI), and classifying pain is sometimes a challenge. The objective of this study was to test the usefulness of the Swedish version of the screening tools Douleur Neuropathique 4 questions (DN4), the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), the Neuropathic Pain Questionnaire (NPQ), and the painDETECT Questionnaire (PD-Q) in individuals with SCI and pain. A further objective was to define pain descriptors able to discriminate neuropathic pain from nonneuropathic pain. Forty individuals with SCI ≥1 year and pain ≥6 months were examined by a specialised physician and assessed twice using the 4 screening tools. The analysis included tests of reliability (test-retest) and validity (calculation of sensitivity, specificity, and overall agreement), an explorative analysis of the cutoff scores and regression analysis for identifying predictors of diagnostic accuracy. Our results indicate that reliability was good to very good for 3 of the screening tools, DN4, LANSS, and NPQ with a Cohen's kappa coefficient between 0.70 and 1.00. DN4 showed the highest sensitivity (93%), followed by PD-Q (68%), NPQ (50%), and LANSS (36%). LANSS and NPQ demonstrated the highest specificity (100%), followed by PD-Q (83%) and DN4 (75%). Diagnostic accuracy for the tools was for DN4 88%, PD-Q 78%, NPQ 65%, and LANSS 55%. A final model showed that 3 items, hypoesthesia to touch, burning pain, and numbness, could discriminate pain in this cohort of individuals with SCI with a high goodness of fit.

摘要

脊髓损伤(SCI)后常出现神经病理性和伤害感受性疼痛,有时对疼痛进行分类具有挑战性。本研究旨在测试瑞典版筛查工具——4 个问题的神经性疼痛筛查工具(DN4)、利兹神经病症状和体征评估(LANSS)、神经性疼痛问卷(NPQ)和疼痛 DETECT 问卷(PD-Q)在 SCI 伴疼痛患者中的有效性。进一步的目的是确定能够区分神经病理性疼痛和非神经病理性疼痛的疼痛描述符。40 名 SCI 病程≥1 年且疼痛持续≥6 个月的患者接受了专科医生的检查,并使用这 4 种筛查工具进行了两次评估。分析包括可靠性(测试-重测)和有效性(计算敏感性、特异性和总体一致性)测试,对截断值进行探索性分析以及回归分析以确定诊断准确性的预测因子。我们的结果表明,DN4、LANSS 和 NPQ 这 3 种筛查工具的可靠性良好至非常好,Cohen's kappa 系数在 0.70 到 1.00 之间。DN4 的敏感性最高(93%),其次是 PD-Q(68%)、NPQ(50%)和 LANSS(36%)。LANSS 和 NPQ 的特异性最高(100%),其次是 PD-Q(83%)和 DN4(75%)。这 4 种工具的诊断准确性为:DN4 为 88%,PD-Q 为 78%,NPQ 为 65%,LANSS 为 55%。最终模型显示,3 项指标(触觉减退、烧灼感和麻木感)可以区分 SCI 患者的疼痛,拟合优度高。

相似文献

1
Screening tools for neuropathic pain: can they be of use in individuals with spinal cord injury?神经病理性疼痛的筛查工具:它们对脊髓损伤患者有用吗?
Pain. 2011 Apr;152(4):772-779. doi: 10.1016/j.pain.2010.11.019. Epub 2011 Jan 26.
2
Reliability and validity of simplified Chinese version of Spinal Cord Injury Pain Instrument in patients with spinal cord injury in mainland China.中国大陆脊髓损伤患者脊髓损伤疼痛评估工具简化中文版的信度和效度。
Disabil Rehabil. 2024 Sep;46(18):4295-4299. doi: 10.1080/09638288.2023.2261377. Epub 2023 Sep 22.
3
Usefulness of the DN4, S-LANSS, and painDETECT screening questionnaires to detect the neuropathic pain components in people with acute whiplash-associated disorders: a cross-sectional study.DN4、S-LANSS 和 painDETECT 筛查问卷在检测急性挥鞭样损伤相关疾病患者神经病理性疼痛成分中的效用:一项横断面研究。
Pain Med. 2024 May 2;25(5):344-351. doi: 10.1093/pm/pnad165.
4
Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study.疼痛 DETECT 问卷土耳其语版用于评估神经性疼痛的有效性和可靠性研究。
Pain Med. 2013 Dec;14(12):1933-43. doi: 10.1111/pme.12222. Epub 2013 Aug 7.
5
Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.两种问卷在西班牙人群中检测神经性疼痛的诊断准确性。
Eur J Pain. 2014 Jan;18(1):101-9. doi: 10.1002/j.1532-2149.2013.00350.x. Epub 2013 Jun 17.
6
Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.下背部相关腿痛患者中,神经病理性症状和体征的自我报告利兹评估与神经病理性疼痛4问题筛查工具之间的一致性和相关性。
J Manipulative Physiol Ther. 2012 Mar-Apr;35(3):196-202. doi: 10.1016/j.jmpt.2012.02.001. Epub 2012 Mar 6.
7
Psychometric and accuracy comparison of three commonly used questionnaires for the diagnosis of neuropathic pain.三种常用神经病理性疼痛诊断问卷的心理测量学及准确性比较
Saudi J Anaesth. 2021 Oct-Dec;15(4):409-418. doi: 10.4103/sja.sja_352_21. Epub 2021 Sep 2.
8
Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain.跨文化调适与义大利文版 Leeds 评估神经性症状与体征量表和 Pain DETECT 问卷的验证:用于区分伤害感受性疼痛与神经性疼痛。
Pain Res Manag. 2021 Apr 28;2021:6623651. doi: 10.1155/2021/6623651. eCollection 2021.
9
Neuropathic Pain Questionnaire and Neuropathic Pain Questionnaire-Short Form: Translation, Reliability, and Validation Study of the Turkish Version.神经性疼痛问卷和神经性疼痛问卷简表:土耳其语版本的翻译、信度和效度研究
Turk Neurosurg. 2019;29(5):683-688. doi: 10.5137/1019-5149.JTN.25466-18.1.
10
Validation of a New Arabic Version of the Neuropathic Pain Diagnostic Questionnaire (DN4).新版阿拉伯语版神经性疼痛诊断问卷(DN4)的验证
Pain Pract. 2017 Jan;17(1):78-87. doi: 10.1111/papr.12419. Epub 2016 Feb 20.

引用本文的文献

1
Neuropathic pain appears to be the main symptom associated with higher disease burden and lower pain alleviation in degenerative lumbar disease fusion patients.神经性疼痛似乎是退行性腰椎疾病融合患者中与更高疾病负担和更低疼痛缓解相关的主要症状。
Brain Spine. 2025 Feb 25;5:104224. doi: 10.1016/j.bas.2025.104224. eCollection 2025.
2
The effects of lowering barometric pressure on pain behavior and the stress hormone in mice with neuropathic pain.降低气压对神经性疼痛小鼠疼痛行为和应激激素的影响。
PLoS One. 2025 Jan 17;20(1):e0317767. doi: 10.1371/journal.pone.0317767. eCollection 2025.
3
The influence of pain on community reintegration after spinal cord injury.
疼痛对脊髓损伤后重返社区的影响。
Pain Pract. 2025 Jan;25(1):e13439. doi: 10.1111/papr.13439. Epub 2024 Nov 19.
4
Long-term subjective and objective outcomes after digital nerve repair: a cohort study.指神经修复后的长期主观和客观结果:一项队列研究。
J Hand Surg Eur Vol. 2025 May;50(5):649-658. doi: 10.1177/17531934241286116. Epub 2024 Oct 13.
5
"I don't know the correct way to describe it": neuropathic pain experiences among athletes with spinal cord injury.“我不知道描述它的正确方式”:脊髓损伤运动员的神经性疼痛体验
BMJ Open Sport Exerc Med. 2024 Aug 3;10(3):e001828. doi: 10.1136/bmjsem-2023-001828. eCollection 2024.
6
The problem of residual pain in the assessment of rheumatoid arthritis activity.类风湿关节炎活动度评估中的残留疼痛问题。
Reumatologia. 2024;62(3):176-186. doi: 10.5114/reum/189779. Epub 2024 Jul 12.
7
Post-polio syndrome - somatosensory dysfunction and its relation to pain: a pilot study with quantitative sensory testing.肌萎缩侧索硬化后综合征-躯体感觉功能障碍及其与疼痛的关系:一项使用定量感觉测试的初步研究。
J Rehabil Med. 2024 Jun 25;56:jrm26192. doi: 10.2340/jrm.v56.26192.
8
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury.一项随机、双盲、安慰剂对照、平行分组、多中心、IIA 期临床试验,旨在评估每日口服 NFX88 治疗脊髓损伤患者神经性疼痛的安全性、耐受性和疗效。
Spinal Cord. 2024 Aug;62(8):454-467. doi: 10.1038/s41393-024-01006-4. Epub 2024 Jun 19.
9
Usefulness of the DN4, S-LANSS, and painDETECT screening questionnaires to detect the neuropathic pain components in people with acute whiplash-associated disorders: a cross-sectional study.DN4、S-LANSS 和 painDETECT 筛查问卷在检测急性挥鞭样损伤相关疾病患者神经病理性疼痛成分中的效用:一项横断面研究。
Pain Med. 2024 May 2;25(5):344-351. doi: 10.1093/pm/pnad165.
10
Central neuropathic pain.中枢神经性疼痛。
Nat Rev Dis Primers. 2023 Dec 21;9(1):73. doi: 10.1038/s41572-023-00484-9.